AbbVie Inc. Revenue 2011–2025
AbbVie Inc. reported $61.16B of revenue for fiscal 2025. That was 8.6% higher than fiscal 2024. Compared with fiscal 2020, the change was +33.5%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $61.16B | +8.6% |
| FY 2024 | $56.33B | +3.7% |
| FY 2023 | $54.32B | -6.4% |
| FY 2022 | $58.05B | +3.3% |
| FY 2021 | $56.20B | +22.7% |
| FY 2020 | $45.80B | +37.7% |
| FY 2019 | $33.27B | +1.6% |
| FY 2018 | $32.75B | +16.1% |
| FY 2017 | $28.22B | +10.1% |
| FY 2016 | $25.64B | +12.2% |
| FY 2015 | $22.86B | +14.5% |
| FY 2014 | $19.96B | +6.2% |
| FY 2013 | $18.79B | +2.2% |
| FY 2012 | $18.38B | +5.4% |
| FY 2011 | $17.44B | — |
Source: AbbVie Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ABBV 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
AbbVie Inc. reported $61.16B of revenue for fiscal 2025. That was 8.6% higher than fiscal 2024. Compared with fiscal 2020, the change was +33.5%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for AbbVie Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAbbVie Inc. — frequently asked questions
What is AbbVie Inc.'s revenue?
AbbVie Inc. (ABBV) reported revenue of $61.16B for fiscal year 2025, per its SEC filings.
How has AbbVie Inc.'s revenue changed over time?
Between fiscal 2011 and 2025, ABBV's revenue grew at roughly 9.4% per year (compound annual rate), from $17.44B to $61.16B.
Where does this data come from?
Figures are computed from AbbVie Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.